Literature DB >> 9486678

Botulinum toxin therapy for palmar hyperhidrosis.

W B Shelley1, N Y Talanin, E D Shelley.   

Abstract

BACKGROUND: Severe palmar hyperhidrosis is a chronic disease, resistant to conventional therapy. Botulinum toxin inhibits sweat production by blocking release of acetylcholine from presynaptic membranes.
OBJECTIVE: Our purpose was to evaluate the short- and long-term effectiveness of botulinum toxin therapy in treatment of palmar hyperhidrosis.
METHODS: Four patients with severe palmar hyperhidrosis were treated with subepidermal injections of botulinum toxin. Fifty injections, 2 mouse units each, were used in each palm. Regional nerve blocks of the median and ulnar nerves were performed before the procedure. Patients were observed for 12 months after treatment.
RESULTS: Botulinum toxin injections significantly reduced sweat production in the treated areas of the palms. Anhidrosis lasted for 12 months in one patient, 7 months in two patients, and 4 months in one patient. Mild weakness of the thumb lasting 3 weeks occurred in one patient. No other side effects were observed.
CONCLUSION: Botulinum toxin provides an effective, safe, and long-lasting alternative therapeutic modality for treatment of severe palmar hyperhidrosis. Additional studies are needed for optimization of the technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486678     DOI: 10.1016/s0190-9622(98)70242-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Treating hyperhidrosis. Surgery and botulinum toxin are treatments of choice in severe cases.

Authors:  J Collin; P Whatling
Journal:  BMJ       Date:  2000-05-06

Review 2.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

3.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

4.  Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.

Authors:  M Naumann; N J Lowe
Journal:  BMJ       Date:  2001-09-15

5.  Sympathectomy for hyperhidrosis: should we place the clamps at T2-T3 or T3-T4?

Authors:  Rafael Reisfeld
Journal:  Clin Auton Res       Date:  2006-11-02       Impact factor: 4.435

6.  Botulinum toxin.

Authors:  P K Nigam; Anjana Nigam
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

7.  Economic evaluation of botulinum toxin versus thoracic sympathectomy for palmar hyperhidrosis: data from a real-world scenario.

Authors:  Beatriz Isla-Tejera; Juan Ruano; María A Alvarez; Teresa Brieva; Manuel Cárdenas; Carlos Baamonde; Angel Salvatierra; José-Ramón Del Prado-Llergo; José C Moreno-Giménez
Journal:  Dermatol Ther (Heidelb)       Date:  2013-05-14

Review 8.  Botulinum toxin the poison that heals: A brief review.

Authors:  Shubha Ranjan Dutta; Deepak Passi; Mahinder Singh; Purnima Singh; Sarang Sharma; Abhimanyu Sharma
Journal:  Natl J Maxillofac Surg       Date:  2016 Jan-Jun

9.  Bilateral thoracoscopic sympathectomy for primary hyperhydrosis: a review of 335 cases.

Authors:  Murat Oncel; Güven Sadi Sunam; Esref Erdem; Yüksel Dereli; Bekir Tezcan; Kazim Gürol Akyol
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

Review 10.  Current trends in needle-free jet injection: an update.

Authors:  Daniel Barolet; Antranik Benohanian
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.